THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Udho Thadani to Angina Pectoris

Back to Details
This is a "connection" page, showing publications Udho Thadani has written about Angina Pectoris.
Udho Thadani
Connection Strength
7.665
Angina Pectoris
  1. Editorial commentary: Treatment of refractory angina: An ongoing challenge. Trends Cardiovasc Med. 2018 04; 28(3):229-230.
    View in: PubMed
    Score: 0.569
  2. The risk of cardiovascular side effects with anti-anginal drugs. Expert Opin Drug Saf. 2016 Dec; 15(12):1609-1623.
    View in: PubMed
    Score: 0.524
  3. Exercise performance, physical activity, and health-related quality of life in participants with stable angina. Angiology. 2011 Aug; 62(6):461-6.
    View in: PubMed
    Score: 0.357
  4. Side effects of using nitrates to treat angina. Expert Opin Drug Saf. 2006 Sep; 5(5):667-74.
    View in: PubMed
    Score: 0.261
  5. Therapy of stable angina pectoris: the uncomplicated patient. Circulation. 2005 Oct 11; 112(15):e255-9.
    View in: PubMed
    Score: 0.245
  6. Current medical management of chronic stable angina. J Cardiovasc Pharmacol Ther. 2004 Sep; 9 Suppl 1:S11-29; quiz S98-9.
    View in: PubMed
    Score: 0.227
  7. Prevention of nitrate tolerance with angiotensin II receptor type 1 blocker in patients with stable angina: yet another failed strategy to prevent tolerance. Cardiovasc Drugs Ther. 2004 Sep; 18(5):339-42.
    View in: PubMed
    Score: 0.227
  8. Recurrent and refractory angina following revascularization procedures in patients with stable angina pectoris. Coron Artery Dis. 2004 May; 15 Suppl 1:S1-4.
    View in: PubMed
    Score: 0.222
  9. Selective L-type, T-type, and nonspecific calcium-channel blockers for stable angina pectoris. Am Heart J. 2002 Jul; 144(1):8-10.
    View in: PubMed
    Score: 0.195
  10. Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure. Heart Dis. 1999 Nov-Dec; 1(5):279-88.
    View in: PubMed
    Score: 0.162
  11. Trimetazidine for stable and unstable ischemic heart diseases and for heart failure: Is its routine use justified from available data? Int J Cardiol. 2020 02 01; 300:45-46.
    View in: PubMed
    Score: 0.159
  12. Treatment of stable angina. Curr Opin Cardiol. 1999 Jul; 14(4):349-58.
    View in: PubMed
    Score: 0.159
  13. Choosing the most appropriate treatment for stable angina. Safety considerations. Drug Saf. 1998 Jul; 19(1):23-44.
    View in: PubMed
    Score: 0.148
  14. Management of patients with chronic stable angina at low risk for serious cardiac events. Am J Cardiol. 1997 Jun 26; 79(12B):24-30.
    View in: PubMed
    Score: 0.138
  15. Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris. Am J Cardiol. 1997 Apr 15; 79(8):1025-30.
    View in: PubMed
    Score: 0.136
  16. Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure. Cardiovasc Drugs Ther. 1997 Jan; 10(6):735-42.
    View in: PubMed
    Score: 0.133
  17. Chronic stable angina pectoris. Strategies for effective drug therapy. Postgrad Med. 1995 Dec; 98(6):175-6, 179-83, 187-8.
    View in: PubMed
    Score: 0.124
  18. Short and long-acting oral nitrates for stable angina pectoris. Cardiovasc Drugs Ther. 1994 Aug; 8(4):611-23.
    View in: PubMed
    Score: 0.113
  19. Ointments and transdermal nitroglycerin patches for stable angina pectoris. Cardiovasc Drugs Ther. 1994 Aug; 8(4):625-33.
    View in: PubMed
    Score: 0.113
  20. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group. Circulation. 1994 Aug; 90(2):726-34.
    View in: PubMed
    Score: 0.113
  21. Challenges with nitrate therapy and nitrate tolerance: prevalence, prevention, and clinical relevance. Am J Cardiovasc Drugs. 2014 Aug; 14(4):287-301.
    View in: PubMed
    Score: 0.113
  22. Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group. Am J Cardiol. 1994 Jul 01; 74(1):9-17.
    View in: PubMed
    Score: 0.112
  23. Duration of effects of isradipine during twice daily therapy in angina pectoris. Cardiovasc Drugs Ther. 1994 Apr; 8(2):199-210.
    View in: PubMed
    Score: 0.110
  24. Mononitrates: defining the ideal long-acting nitrate. Clin Ther. 1994 Mar-Apr; 16(2):130-9; discussion 129.
    View in: PubMed
    Score: 0.110
  25. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate. Ann Intern Med. 1994 Mar 01; 120(5):353-9.
    View in: PubMed
    Score: 0.110
  26. Nitrate therapy and the development of tolerance. Arch Fam Med. 1993 Aug; 2(8):880-5.
    View in: PubMed
    Score: 0.105
  27. Efficacy of isosorbide mononitrate in angina pectoris. Am J Cardiol. 1992 Nov 27; 70(17):67G-71G.
    View in: PubMed
    Score: 0.100
  28. Role of nitrates in angina pectoris. Am J Cardiol. 1992 Sep 24; 70(8):43B-53B.
    View in: PubMed
    Score: 0.099
  29. Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris. Am J Cardiol. 1992 Aug 01; 70(3):286-92.
    View in: PubMed
    Score: 0.098
  30. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris. Circulation. 1991 Dec; 84(6):2398-408.
    View in: PubMed
    Score: 0.094
  31. Medical therapy of stable angina pectoris. Cardiol Clin. 1991 Feb; 9(1):73-87.
    View in: PubMed
    Score: 0.088
  32. Amlodipine: a once-daily calcium antagonist in the treatment of angina pectoris--a parallel dose-response, placebo-controlled study. The Amlodipine Study Group. Am Heart J. 1989 Nov; 118(5 Pt 2):1135.
    View in: PubMed
    Score: 0.081
  33. Long-term bepridil monotherapy for angina pectoris. Am J Cardiol. 1988 Jun 01; 61(15):1210-3.
    View in: PubMed
    Score: 0.074
  34. Amlodipine--a once-daily calcium antagonist in the treatment of angina pectoris: a parallel dose-response placebo-controlled study. J Cardiovasc Pharmacol. 1988; 12 Suppl 7:S114.
    View in: PubMed
    Score: 0.071
  35. Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris. Am J Cardiol. 1987 Sep 01; 60(7):477-82.
    View in: PubMed
    Score: 0.070
  36. Nitrate therapy: continuous or pulse dosing. Ration Drug Ther. 1987 Jul; 21(7):1-6.
    View in: PubMed
    Score: 0.069
  37. Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy. Clin Pharmacol Ther. 1987 Jul; 42(1):58-65.
    View in: PubMed
    Score: 0.069
  38. Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris. Am J Cardiol. 1987 Apr 01; 59(8):756-62.
    View in: PubMed
    Score: 0.068
  39. The effectiveness of transcutaneous nitrate preparations for angina pectoris. Int J Cardiol. 1987 Jan; 14(1):9-14.
    View in: PubMed
    Score: 0.067
  40. Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance. Ann Intern Med. 1986 Oct; 105(4):485-92.
    View in: PubMed
    Score: 0.066
  41. Improvement in angina pectoris with alpha adrenoceptor blockade. Br Heart J. 1986 Feb; 55(2):219-20.
    View in: PubMed
    Score: 0.063
  42. Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. J Am Coll Cardiol. 2005 Nov 15; 46(10):1803-11.
    View in: PubMed
    Score: 0.061
  43. Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris. Am J Cardiol. 1985 Mar 15; 55(7):36C-42C.
    View in: PubMed
    Score: 0.059
  44. Modified-release formulation of trimetazidine for exceptional control of angina pectoris: fact or fiction. Am J Cardiovasc Drugs. 2005; 5(5):331-4.
    View in: PubMed
    Score: 0.058
  45. Assessment of "optimal" beta blockade in treating patients with angina pectoris. Acta Med Scand Suppl. 1985; 694:178-87.
    View in: PubMed
    Score: 0.058
  46. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris. Z Kardiol. 1985; 74 Suppl 4:21-4.
    View in: PubMed
    Score: 0.058
  47. Nitrates for angina pectoris. A critical review of therapeutic efficacy and tolerance. Herz. 1984 Jun; 9(3):123-36.
    View in: PubMed
    Score: 0.056
  48. Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial. J Am Coll Cardiol. 2003 Dec 17; 42(12):2049-59.
    View in: PubMed
    Score: 0.054
  49. Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina. Eur Heart J. 2003 Dec; 24(24):2206-12.
    View in: PubMed
    Score: 0.054
  50. Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris. Am J Cardiol. 2003 Feb 01; 91(3):274-9.
    View in: PubMed
    Score: 0.051
  51. Interaction of indomethacin and nitroglycerin on hemodynamics and exercise tolerance in patients with angina pectoris. Z Kardiol. 1983; 72 Suppl 3:35-9.
    View in: PubMed
    Score: 0.051
  52. Beta adrenergic blocking agents for exertional angina pectoris. Herz. 1982 Jun; 7(3):179-87.
    View in: PubMed
    Score: 0.049
  53. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy. Am J Cardiol. 1982 Feb 01; 49(2):411-9.
    View in: PubMed
    Score: 0.047
  54. Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy. Circulation. 1980 Sep; 62(3):491-502.
    View in: PubMed
    Score: 0.043
  55. Propranolol in angina pectoris: comparison of therapy given two and four times daily. Am J Cardiol. 1980 Jul; 46(1):117-23.
    View in: PubMed
    Score: 0.042
  56. Are the clinical and hemodynamic events during exercise stress testing in invasive studies in patients with angina pectoris reproducible? Circulation. 1980 Apr; 61(4):744-50.
    View in: PubMed
    Score: 0.042
  57. Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate. Circulation. 1980 Mar; 61(3):526-35.
    View in: PubMed
    Score: 0.042
  58. Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris. Am J Med. 1980 Feb; 68(2):243-50.
    View in: PubMed
    Score: 0.041
  59. Effects of low and high glucose in a glucose-insulin-potassium infusion on hemodynamics and exercise tolerance in patients with angina pectoris. Circulation. 1980 Feb; 61(2):266-76.
    View in: PubMed
    Score: 0.041
  60. Reproducibility of clinical and hemodynamic parameters during pacing stress testing in patients with angina pectoris. Circulation. 1979 Nov; 60(5):1036-44.
    View in: PubMed
    Score: 0.041
  61. Clinical, hemodynamic and metabolic responses during pacing in the supine and sitting postures in patients with angina pectoris. Am J Cardiol. 1979 Aug; 44(2):249-56.
    View in: PubMed
    Score: 0.040
  62. Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration. Am J Cardiol. 1979 Jul; 44(1):118-25.
    View in: PubMed
    Score: 0.040
  63. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris. N Engl J Med. 1979 Apr 05; 300(14):750-5.
    View in: PubMed
    Score: 0.039
  64. Propranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapy. Circulation. 1979 Mar; 59(3):571-9.
    View in: PubMed
    Score: 0.039
  65. Effects of glucose-insulin-potassium infusion on the angina response during treadmill exercise. Cardiology. 1979; 64(6):333-49.
    View in: PubMed
    Score: 0.038
  66. Influence of glyceryl trinitrate during supine and upright exercise in patients with angina pectoris. Br Heart J. 1978 Nov; 40(11):1229-36.
    View in: PubMed
    Score: 0.038
  67. Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group. Am J Cardiol. 1997 Aug 15; 80(4):421-5.
    View in: PubMed
    Score: 0.035
  68. Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris. Zatebradine Investigators. Am J Cardiol. 1997 May 15; 79(10):1401-5.
    View in: PubMed
    Score: 0.034
  69. Oral nitrates: more than symptomatic therapy in coronary artery disease? Cardiovasc Drugs Ther. 1997 May; 11 Suppl 1:213-8.
    View in: PubMed
    Score: 0.034
  70. Oxprenolol in angina pectoris [proceedings]. Br J Pharmacol. 1976 Nov; 58(3):412P.
    View in: PubMed
    Score: 0.033
  71. Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial. Am Heart J. 1995 Mar; 129(3):527-35.
    View in: PubMed
    Score: 0.029
  72. Conversion from immediate-release to extended-release diltiazem in angina pectoris. Clin Cardiol. 1994 Sep; 17(9):484-8.
    View in: PubMed
    Score: 0.028
  73. Comparison of adrenergic beta-receptor antagonists in angina pectoris. Br Med J. 1973 Jan 20; 1(5846):138-42.
    View in: PubMed
    Score: 0.025
  74. Nitrate tolerance. How to prevent it or minimize its effect. Postgrad Med. 1992 Apr; 91(5):307-12, 315-8.
    View in: PubMed
    Score: 0.024
  75. Nitrate therapy for myocardial ischemic syndrome: current perspectives including tolerance. Curr Probl Cardiol. 1988 Nov; 13(11):723-84.
    View in: PubMed
    Score: 0.019
  76. Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates. Clin Pharmacokinet. 1988 Jul; 15(1):32-43.
    View in: PubMed
    Score: 0.018
  77. Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily. Am J Cardiol. 1981 May; 47(5):1123-7.
    View in: PubMed
    Score: 0.011
  78. Slow release oxprenolol in angina pectoris [proceedings]. Br J Clin Pharmacol. 1977 Jun; 4(3):387P.
    View in: PubMed
    Score: 0.009
  79. Hemodynamics at rest and during supine and sitting bicycle exercise in patients with coronary artery disease. Am J Cardiol. 1977 May 26; 39(6):776-83.
    View in: PubMed
    Score: 0.009
  80. Proceedings: Left ventricular pressure-volume changes during exercise-induced pain in patients with angina pectoris. Br Heart J. 1974 Oct; 36(10):1038.
    View in: PubMed
    Score: 0.007
  81. Cardiovascular effects of weight reduction in obese patients with angina pectoris. Br Heart J. 1974 Sep; 36(9):854-8.
    View in: PubMed
    Score: 0.007
  82. Kinetics of isosorbide dinitrate and relationships to pharmacological effects. Br J Clin Pharmacol. 1981 Jun; 11(6):579-89.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES